BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Business

  Rachel McMinn Promoted To Senior Biotechnology Research Analyst At Piper Jaffray

  January 26, 2006

   · 

  1 min read
• Business

  ImmuneRegen BioSciences, Inc. Appoints James Robert Campbell, Ph.D., To Bioterrorism Preparedness Advisory Board

  January 26, 2006

   · 

  3 min read
• Business

  Neurologix, Inc. Announces Appointment Of Marc Panoff As Chief Financial Officer

  January 26, 2006

   · 

  1 min read
• Drug Development

  BioMS Medical Retains ICON Clinical Research, Inc. For Pivotal Multiple Sclerosis Trial

  January 26, 2006

   · 

  1 min read
• Business

  Ambit Biosciences Corporation Appoints Donald R. Myll Senior Vice President Commercial Operations And Chief Financial Officer

  January 26, 2006

   · 

  1 min read
• FDA

  European Commission Approves Pfizer Inc.'s Exubera(R) For Treatment Of Type 1 And Type 2 Diabetes

  January 26, 2006

   · 

  6 min read
• Business

  Amgen’s Fourth Quarter 2005 Adjusted Earnings Per Share Increased 29 Percent To 75 Cents

  January 26, 2006

   · 

  1 min read
• Business

  Dainippon Sumitomo Pharma Co., Ltd. And ASKA Pharmaceutical To Dissolve Dealing Contract

  January 26, 2006

   · 

  1 min read
• Drug Development

  Point Therapeutics Announces Time Change For January 31, 2006 Webcast; Webcast On Phase 3 NSCLC Program And Clinical Update Moved To 8:30 AM EST

  January 26, 2006

   · 

  1 min read
• Business

  Callisto Pharmaceuticals Announces Licensing Of A New Class Of Cancer Drugs With A Novel Mechanism Of Action, Showing Potent Antitumor Activity

  January 26, 2006

   · 

  5 min read